Personal Capital Advisors Corp bought a new stake in Masimo Co. (NASDAQ:MASI) during the third quarter, Holdings Channel reports. The institutional investor bought 2,013 shares of the medical equipment provider’s stock, valued at approximately $251,000.
Several other institutional investors have also made changes to their positions in the company. United Services Automobile Association increased its holdings in shares of Masimo by 0.7% in the 2nd quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock valued at $6,983,000 after acquiring an additional 485 shares during the period. Moody Aldrich Partners LLC acquired a new position in shares of Masimo in the 2nd quarter valued at $2,919,000. Public Employees Retirement System of Ohio increased its holdings in shares of Masimo by 57.7% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 50,161 shares of the medical equipment provider’s stock valued at $4,898,000 after acquiring an additional 18,350 shares during the period. Schroder Investment Management Group increased its holdings in shares of Masimo by 77.2% in the 2nd quarter. Schroder Investment Management Group now owns 799,435 shares of the medical equipment provider’s stock valued at $106,225,000 after acquiring an additional 348,169 shares during the period. Finally, Bank of Nova Scotia acquired a new position in shares of Masimo in the 2nd quarter valued at $13,056,000. 83.25% of the stock is currently owned by institutional investors and hedge funds.
Shares of MASI opened at $117.13 on Friday. The firm has a market capitalization of $6.45 billion, a price-to-earnings ratio of 47.81, a PEG ratio of 2.91 and a beta of 1.00. Masimo Co. has a 1 year low of $80.69 and a 1 year high of $126.89.
A number of equities analysts have recently commented on MASI shares. ValuEngine raised shares of Masimo from a “hold” rating to a “buy” rating in a report on Monday, July 2nd. Stifel Nicolaus lifted their target price on shares of Masimo from $112.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 2nd. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $110.00 target price on the stock in a report on Tuesday, July 3rd. BidaskClub raised shares of Masimo from a “buy” rating to a “strong-buy” rating in a report on Friday, August 17th. Finally, Needham & Company LLC assumed coverage on shares of Masimo in a research note on Friday, September 14th. They issued a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $109.20.
In other Masimo news, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $101.00, for a total value of $202,000.00. Following the transaction, the director now directly owns 57,832 shares of the company’s stock, valued at approximately $5,841,032. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Joe E. Kiani sold 60,074 shares of the business’s stock in a transaction on Monday, August 6th. The shares were sold at an average price of $109.05, for a total transaction of $6,551,069.70. Following the completion of the transaction, the chief executive officer now directly owns 168,514 shares in the company, valued at $18,376,451.70. The disclosure for this sale can be found here. Insiders sold a total of 765,380 shares of company stock worth $90,720,456 over the last three months. 12.60% of the stock is currently owned by corporate insiders.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Read More: What is the S&P 500 Index?
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.